Selected article for: "ad development and ad neurodegenerative disease"

Author: Li, Xiao-Jun; Kim, Kwan-Woo; Oh, Hyuncheol; Liu, Xiang-Qian; Kim, Youn-Chul
Title: Chemical Constituents and an Antineuroinflammatory Lignan, Savinin from the Roots of Acanthopanax henryi
  • Document date: 2019_2_21
  • ID: 1vbkttzx_1
    Snippet: Neuroinflammatory responses are mainly mediated by microglial activation, and they are implicated in the development of neurodegenerative diseases such as Alzheimer's diseases (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) [1] . Microglial cells are the primary resident immune cells in the central nervous system (CNS) and are associated with defensive mechanisms to maintain homeostasis against bra.....
    Document: Neuroinflammatory responses are mainly mediated by microglial activation, and they are implicated in the development of neurodegenerative diseases such as Alzheimer's diseases (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) [1] . Microglial cells are the primary resident immune cells in the central nervous system (CNS) and are associated with defensive mechanisms to maintain homeostasis against brain injury [2] . In steady state, microglia exert protective responses by regulating innate and adaptive immune responses. However, activated microglia produce excess immune reactions which are detrimental to brain tissue and can produce various proinflammatory mediators such as tumor necrosis factor-(TNF-) , interleukins (ILs), nitric oxide (NO), prostaglandin E2 (PGE 2 ), and reactive oxygen species (ROS). Released and accumulated, these proinflammatory mediators facilitate the development of neurodegenerative diseases [3, 4] . Therefore, it is important to suppress the secretion of proinflammatory mediators from activated microglial cells to prevent the neuroinflammation-related development of neurodegenerative diseases.

    Search related documents:
    Co phrase search for related documents
    • ad Alzheimer disease and Alzheimer disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • adaptive innate immune response and brain injury: 1, 2
    • adaptive innate immune response and central nervous system: 1, 2, 3, 4
    • adaptive innate immune response and CNS central nervous system: 1, 2, 3, 4
    • adaptive innate immune response and immune cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive innate immune response and immune reaction: 1, 2
    • adaptive innate immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adaptive innate immune response regulate and immune cell: 1, 2
    • adaptive innate immune response regulate and immune response: 1, 2, 3, 4
    • ALS amyotrophic lateral sclerosis and amyotrophic lateral sclerosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ALS amyotrophic lateral sclerosis and central nervous system: 1, 2, 3, 4
    • ALS amyotrophic lateral sclerosis and CNS central nervous system: 1, 2, 3, 4
    • ALS amyotrophic lateral sclerosis and immune response: 1, 2, 3
    • Alzheimer disease and amyotrophic lateral sclerosis: 1, 2, 3
    • Alzheimer disease and brain injury: 1
    • Alzheimer disease and brain tissue: 1
    • Alzheimer disease and central nervous system: 1, 2, 3, 4, 5
    • Alzheimer disease and CNS central nervous system: 1, 2, 3
    • Alzheimer disease and immune response: 1, 2, 3